AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
PHARMACOLOGICAL APPROACHES TO COUNTER THE TOXICITY OF DOPA
Authors: VONVOIGTLANDER PF FICI GJ ALTHAUS JS
Citation: Pf. Vonvoigtlander et al., PHARMACOLOGICAL APPROACHES TO COUNTER THE TOXICITY OF DOPA, Amino acids, 14(1-3), 1998, pp. 189-196
AZULENYL NITRONES - COLORIMETRIC DETECTION OF OXYRADICAL END-PRODUCTSAND NEUROPROTECTION IN THE GERBIL TRANSIENT FOREBRAIN ISCHEMIA REPERFUSION MODEL/
Authors: ALTHAUS JS FLECK TJ BECKER DA HALL ED VONVOIGTLANDER PF
Citation: Js. Althaus et al., AZULENYL NITRONES - COLORIMETRIC DETECTION OF OXYRADICAL END-PRODUCTSAND NEUROPROTECTION IN THE GERBIL TRANSIENT FOREBRAIN ISCHEMIA REPERFUSION MODEL/, Free radical biology & medicine, 24(5), 1998, pp. 738-744
2 IMIDAZOQUINOXALINE LIGANDS FOR THE BENZODIAZEPINE SITE SHARING A 2ND LOW-AFFINITY SITE ON RAT GABA(A) RECEPTORS BUT WITH THE OPPOSITE FUNCTIONALITY
Authors: IM HK IM WB PREGENZER JF STRATMAN NC VONVOIGTLANDER PF JACOBSEN EJ
Citation: Hk. Im et al., 2 IMIDAZOQUINOXALINE LIGANDS FOR THE BENZODIAZEPINE SITE SHARING A 2ND LOW-AFFINITY SITE ON RAT GABA(A) RECEPTORS BUT WITH THE OPPOSITE FUNCTIONALITY, British Journal of Pharmacology, 123(8), 1998, pp. 1490-1494
ANXIOLYTIC-LIKE EFFECTS OF PNU-101017, A PARTIAL AGONIST AT THE BENZODIAZEPINE RECEPTOR
Authors: TANG AH FRANKLIN SR CARTER DB SETHY VH NEEDHAM LM JACOBSEN EJ VONVOIGTLANDER PF
Citation: Ah. Tang et al., ANXIOLYTIC-LIKE EFFECTS OF PNU-101017, A PARTIAL AGONIST AT THE BENZODIAZEPINE RECEPTOR, Psychopharmacology, 131(3), 1997, pp. 255-263
EFFECTS OF LAZAROIDS AND A PEROXYNITRITE SCAVENGER IN A CELL MODEL OFPEROXYNITRITE TOXICITY
Authors: FICI GJ ALTHAUS JS VONVOIGTLANDER PF
Citation: Gj. Fici et al., EFFECTS OF LAZAROIDS AND A PEROXYNITRITE SCAVENGER IN A CELL MODEL OFPEROXYNITRITE TOXICITY, Free radical biology & medicine, 22(1-2), 1997, pp. 223-228
PROTEIN NITRATION BY PEROXYNITRITE - A METHOD FOR MONITORING NITRIC-OXIDE NEUROTOXICITY
Authors: ALTHAUS JS FICI GJ PLAISTED SM KEZDY FJ CAMPBELL CM HOOGERHEIDE JG VONVOIGTLANDER PF
Citation: Js. Althaus et al., PROTEIN NITRATION BY PEROXYNITRITE - A METHOD FOR MONITORING NITRIC-OXIDE NEUROTOXICITY, Microchemical journal, 56(2), 1997, pp. 155-164
D-1 DOPAMINE-RECEPTOR ACTIVITY OF ANTI-PARKINSONIAN DRUGS
Authors: FICI GJ WU H VONVOIGTLANDER PF SETHY VH
Citation: Gj. Fici et al., D-1 DOPAMINE-RECEPTOR ACTIVITY OF ANTI-PARKINSONIAN DRUGS, Life sciences, 60(18), 1997, pp. 1597-1603
PYRROLOPYRIMIDINES - NOVEL BRAIN-PENETRATING ANTIOXIDANTS WITH NEUROPROTECTIVE ACTIVITY IN BRAIN INJURY AND ISCHEMIA MODELS
Authors: HALL ED ANDRUS PK SMITH SL FLECK TJ SCHERCH HM LUTZKE BS SAWADA GA ALTHAUS JS VONVOIGTLANDER PF PADBURY GE LARSON PG PALMER JR BUNDY GL
Citation: Ed. Hall et al., PYRROLOPYRIMIDINES - NOVEL BRAIN-PENETRATING ANTIOXIDANTS WITH NEUROPROTECTIVE ACTIVITY IN BRAIN INJURY AND ISCHEMIA MODELS, The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 895-904
PNU-107484A WITH ALPHA-ISOFORM-DEPENDENT FUNCTIONAL-CHANGES IN ALPHA-X-BETA-2-GAMMA-2 SUBTYPES OF RAT RECOMBINANT GABA(A) RECEPTORS
Authors: IM HK IM WB CARTER DB SCHWARTZ TM BUNDY GL VONVOIGTLANDER PF
Citation: Hk. Im et al., PNU-107484A WITH ALPHA-ISOFORM-DEPENDENT FUNCTIONAL-CHANGES IN ALPHA-X-BETA-2-GAMMA-2 SUBTYPES OF RAT RECOMBINANT GABA(A) RECEPTORS, British Journal of Pharmacology, 122(5), 1997, pp. 821-824
PROTECTIVE EFFECTS OF TIRILAZAD MESYLATE IN A CELLULAR-MODEL OF PEROXYNITRITE TOXICITY
Authors: FICI GJ ALTHAUS JS HALL ED VONVOIGTLANDER PF
Citation: Gj. Fici et al., PROTECTIVE EFFECTS OF TIRILAZAD MESYLATE IN A CELLULAR-MODEL OF PEROXYNITRITE TOXICITY, Research communications in molecular pathology and pharmacology, 91(3), 1996, pp. 357-371
THYROID HORMONAL MODULATION OF THE BINDING AND ACTIVITY OF THE GABA(A) RECEPTOR COMPLEX OF BRAIN
Authors: MARTIN JV WILLIAMS DB FITZGERALD RM IM HK VONVOIGTLANDER PF
Citation: Jv. Martin et al., THYROID HORMONAL MODULATION OF THE BINDING AND ACTIVITY OF THE GABA(A) RECEPTOR COMPLEX OF BRAIN, Neuroscience, 73(3), 1996, pp. 705-713
PHARMACOLOGICAL CHARACTERIZATION OF U-101387, A DOPAMINE D4 RECEPTOR-SELECTIVE ANTAGONIST
Authors: MERCHANT KM GILL GS HARRIS DW HUFF RM EATON MJ LOOKINGLAND K LUTZKE BS MCCALL RB PIERCEY MF SCHREUR PJKD SETHY VH SMITH MW SVENSSON KA TANG AH VONVOIGTLANDER PF TENBRINK RE
Citation: Km. Merchant et al., PHARMACOLOGICAL CHARACTERIZATION OF U-101387, A DOPAMINE D4 RECEPTOR-SELECTIVE ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1392-1403
THYROID HORMONAL INFLUENCES ON THE BINDING AND EFFECTOR MECHANISM OF THE GABA(A) RECEPTOR COMPLEX OF BRAIN
Authors: MARTIN JV WILLIAMS DB LEE K LEE H IM HK VONVOIGTLANDER PF
Citation: Jv. Martin et al., THYROID HORMONAL INFLUENCES ON THE BINDING AND EFFECTOR MECHANISM OF THE GABA(A) RECEPTOR COMPLEX OF BRAIN, Journal of neurochemistry, 66, 1996, pp. 58-58
3-PHENYL-SUBSTITUTED IMIDAZO[1,5-A]QUINOXALIN-4-ONES AND IMIDAZO[1,5-A]QUINOXALINE UREAS THAT HAVE HIGH-AFFINITY AT THE GABA(A) BENZODIAZEPINE RECEPTOR COMPLEX/
Authors: JACOBSEN EJ STELZER LS BELONGA KL CARTER DB IM WB SETHY VH TANG AH VONVOIGTLANDER PF PETKE JD
Citation: Ej. Jacobsen et al., 3-PHENYL-SUBSTITUTED IMIDAZO[1,5-A]QUINOXALIN-4-ONES AND IMIDAZO[1,5-A]QUINOXALINE UREAS THAT HAVE HIGH-AFFINITY AT THE GABA(A) BENZODIAZEPINE RECEPTOR COMPLEX/, Journal of medicinal chemistry, 39(19), 1996, pp. 3820-3836
HIGH-AFFINITY PARTIAL AGONIST IMIDAZOL[1,5-A]QUINOXALINE AMIDES, CARBAMATES, AND UREAS AT THE GAMMA-AMINOBUTYRIC-ACID-A BENZODIAZEPINE RECEPTOR COMPLEX
Authors: JACOBSEN EJ TENBRINK RE STELZER LS BELONGA KL CARTER DB IM HK IM WB SETHY VH TANG AH VONVOIGTLANDER PF PETKE JD
Citation: Ej. Jacobsen et al., HIGH-AFFINITY PARTIAL AGONIST IMIDAZOL[1,5-A]QUINOXALINE AMIDES, CARBAMATES, AND UREAS AT THE GAMMA-AMINOBUTYRIC-ACID-A BENZODIAZEPINE RECEPTOR COMPLEX, Journal of medicinal chemistry, 39(1), 1996, pp. 158-175
PHARMACOLOGY OF U-91356A, AN AGONIST FOR THE DOPAMINE D-2 RECEPTOR SUBTYPE
Authors: PIERCEY MF MOON MW SETHY VH SCHREUR PJKD SMITH MW TANG AH VONVOIGTLANDER PF
Citation: Mf. Piercey et al., PHARMACOLOGY OF U-91356A, AN AGONIST FOR THE DOPAMINE D-2 RECEPTOR SUBTYPE, European journal of pharmacology, 317(1), 1996, pp. 29-38
NEUROPROTECTIVE EFFECTS OF THE DOPAMINE D-2 D-3 AGONIST PRAMIPEXOLE AGAINST POSTISCHEMIC OR METHAMPHETAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL NEURONS/
Authors: HALL ED ANDRUS PK OOSTVEEN JA ALTHAUS JS VONVOIGTLANDER PF
Citation: Ed. Hall et al., NEUROPROTECTIVE EFFECTS OF THE DOPAMINE D-2 D-3 AGONIST PRAMIPEXOLE AGAINST POSTISCHEMIC OR METHAMPHETAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL NEURONS/, Brain research, 742(1-2), 1996, pp. 80-88
CHARACTERIZATION OF U-101017 AS A GABA(A) RECEPTOR-LIGAND OF DUAL FUNCTIONALITY
Authors: IM HK IM WB VONVOIGTLANDER PF CARTER DB MURRAY BH JACOBSEN EJ
Citation: Hk. Im et al., CHARACTERIZATION OF U-101017 AS A GABA(A) RECEPTOR-LIGAND OF DUAL FUNCTIONALITY, Brain research, 714(1-2), 1996, pp. 165-168
ANTIBODY TRANSFORMATION BY PEROXYNITRITE AS DETERMINED USING CAPILLARY ELECTROPHORESIS - A FEASIBILITY STUDY
Authors: ALTHAUS JS FICI GJ VONVOIGTLANDER PF
Citation: Js. Althaus et al., ANTIBODY TRANSFORMATION BY PEROXYNITRITE AS DETERMINED USING CAPILLARY ELECTROPHORESIS - A FEASIBILITY STUDY, Research communications in molecular pathology and pharmacology, 87(3), 1995, pp. 359-366
U-90042, A SEDATIVE HYPNOTIC COMPOUND THAT INTERACTS DIFFERENTIALLY WITH THE GABA(A), RECEPTOR SUBTYPES
Authors: TANG AH SMITH MW CARTER DB IM BW VONVOIGTLANDER PF
Citation: Ah. Tang et al., U-90042, A SEDATIVE HYPNOTIC COMPOUND THAT INTERACTS DIFFERENTIALLY WITH THE GABA(A), RECEPTOR SUBTYPES, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 761-767
STRUCTURE-ACTIVITY-RELATIONSHIP PERTAINING TO THE NORTH-WEST REGION OF THE KAPPA-OPIOID AGONIST, U-50,488
Authors: ZHAO S FREEMAN JP VONVOIGTLANDER PF HOWE WJ SZMUSZKOVICZ J
Citation: S. Zhao et al., STRUCTURE-ACTIVITY-RELATIONSHIP PERTAINING TO THE NORTH-WEST REGION OF THE KAPPA-OPIOID AGONIST, U-50,488, Bioorganic & medicinal chemistry letters, 4(17), 1994, pp. 2139-2144
SYNTHETIC STUDIES TOWARDS A TRANS-3,4-DIAMINE DERIVATIVE OF PIPERIDINE MIMICKING BUSPIRONE
Authors: ZHAO SK GHOSH A DANDREA SV FREEMAN JP VONVOIGTLANDER PF CARTER DB SMITH MW BLINN JR SZMUSZKOVICZ J
Citation: Sk. Zhao et al., SYNTHETIC STUDIES TOWARDS A TRANS-3,4-DIAMINE DERIVATIVE OF PIPERIDINE MIMICKING BUSPIRONE, Heterocycles, 39(1), 1994, pp. 163-170
STRUCTURE-ACTIVITY-RELATIONSHIPS OF PEROXYNITRITE SCAVENGERS AN APPROACH TO NITRIC-OXIDE NEUROTOXICITY
Authors: ALTHAUS JS OIEN TT FICI GJ SCHERCH HM SETHY VH VONVOIGTLANDER PF
Citation: Js. Althaus et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF PEROXYNITRITE SCAVENGERS AN APPROACH TO NITRIC-OXIDE NEUROTOXICITY, Research communications in chemical pathology and pharmacology, 83(3), 1994, pp. 243-254
CHARACTERIZATION OF U-92016A AS A SELECTIVE, ORALLY-ACTIVE, HIGH INTRINSIC ACTIVITY 5-HYDROXYTRYPTAMINE(1A) AGONIST
Authors: MCCALL RB ROMERO AG BIENKOWSKI MJ HARRIS DW MCGUIRE JC PIERCEY MF SHUCK ME SMITH MW SVENSSON KA SCHREUR PJKD CARLSSON A VONVOIGTLANDER PF
Citation: Rb. Mccall et al., CHARACTERIZATION OF U-92016A AS A SELECTIVE, ORALLY-ACTIVE, HIGH INTRINSIC ACTIVITY 5-HYDROXYTRYPTAMINE(1A) AGONIST, The Journal of pharmacology and experimental therapeutics, 271(2), 1994, pp. 875-883
PHARMACOLOGY OF A MIXED 5-HYDROXYTRYPTAMINE(1A) DOPAMINE AGONIST/
Authors: PIERCEY MF TANG AH LAHTI RA VONVOIGTLANDER PF SCHREUR PJKD MCCALL RB LUMRAGAN JT HOFFMANN WE FRANKLIN SR CODE RA SMITH MW SZMUSZKOVICZ J
Citation: Mf. Piercey et al., PHARMACOLOGY OF A MIXED 5-HYDROXYTRYPTAMINE(1A) DOPAMINE AGONIST/, The Journal of pharmacology and experimental therapeutics, 268(3), 1994, pp. 1304-1310
Risultati: 1-25 | 26-37